comparative effectiveness research


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.

comparative effectiveness research

Any head-to-head study of alternative solutions to managing a disease, esp. when such a study examines a broadly representative population of patients and follows them for a long enough time to determine meaningful outcomes. Its goal is to identify which treatment produces the best clinical outcomes for most patients, rather than which is better than a placebo or which influences a laboratory test or other surrogate marker without having an impact on the actual health or longevity of patients.
See also: research
Mentioned in ?
References in periodicals archive ?
Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine.
1 billion in funding, and created an interagency advisory group for comparative effectiveness research (the Federal Coordinating Council for Comparative Research).
Critics of comparative effectiveness research point to several challenges.
Although information on this resource is limited, librarians should be aware that the comparative effectiveness research can serve as a clinical reference tool and assist with evidence-based medicine research.
In March 2009, the Department of Health and Human Services announced that 15 experts would guide investments and coordinate research through the Federal Coordinating Council for Comparative Effectiveness Research.
Philipson, University of Chicago and NBER, "The Impact of Comparative Effectiveness Research on Health and Health Care Spending"
health care of an increased role for comparative effectiveness research and related activities.
Comparative effectiveness research refers to studies that examine head-to-head comparisons between two or more clinical interventions.
Support and disseminate the results of Comparative Effectiveness research to help practitioners and patients chose the best healthcare
Specifically, the bills contain provisions on comparative effectiveness research, generic biologic drugs, and financial conflicts of interest between doctors and drug makers.
Initial national priorities for comparative effectiveness research.

Full browser ?